Argent Minerals (ASX:ARD) - CEO & Managing Director, George Karageorge - The Market Herald

" Argent Minerals (ASX:ARD) restarts drilling at Kempfield thanks to clearing skies

Argent Minerals (ARD) has restarted drilling at the Kempfield Polymetallic Project after rain put a dampener on operations.
Westpac (ASX:WBC) - CEO, Peter King - The Market Herald

" Westpac (ASX:WBC) fined $1.3bn to settle AUSTRAC case

Westpac Banking Corporation (WBC) has agreed to pay $1.3 billion to settle its case with AUSTRAC in the Federal Court of Australia.
88 Energy one step closer to drilling at joint well with Premier Oil

" 88 Energy (ASX:88E) draws similarities between Peregrine and nearly gas field

88 Energy (88E) has drawn similarities between two prospects at Project Peregrine in Alaska and the nearby Willow Oil Field.
Sabre Resources (ASX:SBR) identifies major drill targets at Bonanza project

" Sabre Resources (ASX:SBR) identifies major drill targets at Bonanza project

Sabre Resources (SBR) has identified three major drill targets at the Bonanza Gold Project in the Youanmi Goldfields in Western Australia.
Venus finds more significant gold anomalies at Youanmi

" Focus Minerals (ASX:FML) updates PFS and ore reserve for Coolgardie Gold Project

Focus Minerals (FML) has updated the pre-feasibility study (PFS) and ore reserve for the Coolgardie Gold Project in Western Australia.
Suda Pharmaceuticals (ASX:SUD) - CEO, Dr Michael Baker - The Market Herald

" Suda Pharmaceuticals’ (ASX:SUD) canine trial supports alternative delivery of anagrelide

Suda Pharmaceuticals (SUD) has received the final results from a canine trial of various oral formulations of anagrelide.
Rarex Limited (ASX:REE) - Executive Director, Jeremy Robinson - The Market Herald

" RareX (ASX:REE) finds nickel-copper-PGE targets at Byro East Project

RareX (REE) has identified new nickel-copper-Platinum Group Element (PGE) targets at the Byro East Project in WA.
PharmAust (ASX:PAA) awarded $881K grant for phase one monepantel trial

" PharmAust (ASX:PAA) awarded $881K grant for phase one monepantel trial

PharmAust (PAA) has been granted $881,085 for a phase one clinical trial of monepantel in patients with Motor Neurone Disease (MND).
St Barbara (SBM)- CEO, Craig Jetson - The Market Herald

" St Barbara Mining (ASX:SBM) resumes mining after ground fall at Gwalia

St Barbara Mining (SBM) has resumed works at the Gwalia mine after a ground fall forced the company to temporarily suspend mining.
Ionic Rare Earths (ASX:IXR) - Chairman, Paul Rovira - The Market Herald

" Ionic Rare Earths (ASX:IXR) confirms mineralisation extensions at Makuutu

Ionic Rare Earths (IXR) has received the first lot of assays from resource expansion drilling at the Makuutu Rare Earth Element Project.